Genomic and cellular pathology of lung cancer

Sandy D. Der; Roya Navab; Kota Ishizawa; Ming Sound Tsao

doi:10.2174/157339811797189740

Genomic and cellular pathology of lung cancer

Sandy D. Der, Roya Navab, Kota Ishizawa, Ming Sound Tsao

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Lung cancer comprises of two major clinically relevant types, non-small cell lung cancer (NSCLC) representing about 85% of all cases and small cell lung cancer (SCLC) accounting for the remaining 15%. Despite recent advancements that include new understanding of the molecular mechanisms involved in cancer pathogenesis and introduction of new treatments, lung cancer continues to reign as the leading cause of cancer deaths worldwide. Innovations in genomics-based technologies are becoming rapidly integrated into lung cancer research and the results of these efforts have started to yield tangible advances in improved understanding and treatment of lung cancer.

Original language	English
Pages (from-to)	313-322
Number of pages	10
Journal	Current Respiratory Medicine Reviews
Volume	7
Issue number	5
DOIs	https://doi.org/10.2174/157339811797189740
Publication status	Published - 2011 Oct 1
Externally published	Yes

Keywords

Biomarkers
Cancer stem cell
Cancer-associated fibroblasts
Genomics
Lung cancer
Oncogene
Personalized medicine
Stroma

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Access to Document

10.2174/157339811797189740

Fingerprint Dive into the research topics of 'Genomic and cellular pathology of lung cancer'. Together they form a unique fingerprint.

Cite this

@article{49515048147f4bd1b19f3fb01b84c618,

title = "Genomic and cellular pathology of lung cancer",

abstract = "Lung cancer comprises of two major clinically relevant types, non-small cell lung cancer (NSCLC) representing about 85% of all cases and small cell lung cancer (SCLC) accounting for the remaining 15%. Despite recent advancements that include new understanding of the molecular mechanisms involved in cancer pathogenesis and introduction of new treatments, lung cancer continues to reign as the leading cause of cancer deaths worldwide. Innovations in genomics-based technologies are becoming rapidly integrated into lung cancer research and the results of these efforts have started to yield tangible advances in improved understanding and treatment of lung cancer.",

keywords = "Biomarkers, Cancer stem cell, Cancer-associated fibroblasts, Genomics, Lung cancer, Oncogene, Personalized medicine, Stroma",

author = "Der, {Sandy D.} and Roya Navab and Kota Ishizawa and Tsao, {Ming Sound}",

year = "2011",

month = oct,

day = "1",

doi = "10.2174/157339811797189740",

language = "English",

volume = "7",

pages = "313--322",

journal = "Current Respiratory Medicine Reviews",

issn = "1573-398X",

publisher = "Bentham Science Publishers B.V.",

number = "5",

}

TY - JOUR

T1 - Genomic and cellular pathology of lung cancer

AU - Der, Sandy D.

AU - Navab, Roya

AU - Ishizawa, Kota

AU - Tsao, Ming Sound

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Lung cancer comprises of two major clinically relevant types, non-small cell lung cancer (NSCLC) representing about 85% of all cases and small cell lung cancer (SCLC) accounting for the remaining 15%. Despite recent advancements that include new understanding of the molecular mechanisms involved in cancer pathogenesis and introduction of new treatments, lung cancer continues to reign as the leading cause of cancer deaths worldwide. Innovations in genomics-based technologies are becoming rapidly integrated into lung cancer research and the results of these efforts have started to yield tangible advances in improved understanding and treatment of lung cancer.

AB - Lung cancer comprises of two major clinically relevant types, non-small cell lung cancer (NSCLC) representing about 85% of all cases and small cell lung cancer (SCLC) accounting for the remaining 15%. Despite recent advancements that include new understanding of the molecular mechanisms involved in cancer pathogenesis and introduction of new treatments, lung cancer continues to reign as the leading cause of cancer deaths worldwide. Innovations in genomics-based technologies are becoming rapidly integrated into lung cancer research and the results of these efforts have started to yield tangible advances in improved understanding and treatment of lung cancer.

KW - Biomarkers

KW - Cancer stem cell

KW - Cancer-associated fibroblasts

KW - Genomics

KW - Lung cancer

KW - Oncogene

KW - Personalized medicine

KW - Stroma

UR - http://www.scopus.com/inward/record.url?scp=80052189582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052189582&partnerID=8YFLogxK

U2 - 10.2174/157339811797189740

DO - 10.2174/157339811797189740

M3 - Article

AN - SCOPUS:80052189582

VL - 7

SP - 313

EP - 322

JO - Current Respiratory Medicine Reviews

JF - Current Respiratory Medicine Reviews

SN - 1573-398X

IS - 5

ER -

Genomic and cellular pathology of lung cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this